Literature DB >> 11560952

Accelerated apoptosis in the Timp-3-deficient mammary gland.

J E Fata1, K J Leco, E B Voura, H Y Yu, P Waterhouse, G Murphy, R A Moorehead, R Khokha.   

Abstract

The proapoptotic proteinase inhibitor TIMP-3 is the only molecule of this family thought to influence cell death. We examined epithelial apoptosis in TIMP-3-deficient mice during mammary gland involution. Lactation was not affected by the absence of TIMP-3, but glandular function, as measured by gland-to-body weight ratio and production of beta-casein, was suppressed earlier during post-lactational involution than in controls. Histological examination revealed accelerated lumen collapse, alveolar-epithelial loss, and adipose reconstitution in Timp-3(-/-) females. Epithelial apoptosis peaked on the first day of involution in Timp-3-null glands but at day 3 in wild-type littermates. Unscheduled activation of gelatinase-A was evident by zymography and correlated with earlier fragmentation of fibronectin in Timp-3(-/-) mammary. To obtain independent evidence of the proapoptotic effects of TIMP-3 deficiency, we introduced recombinant TIMP-3-releasing pellets into regressing Timp-3(-/-) mammary tissue and showed that this treatment rescued lumen collapse and epithelial apoptosis. Ex vivo, involuting Timp-3(-/-) mammary tissue demonstrated accelerated epithelial apoptosis that could be reduced by metalloproteinase inhibition. The physiological relevance of TIMP-3 became apparent as Timp-3(-/-) dams failed to reestablish lactation after brief cessation of suckling. Thus, TIMP-3 is a critical epithelial survival factor during mammary gland involution.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11560952      PMCID: PMC200934          DOI: 10.1172/JCI13171

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  68 in total

Review 1.  Control of milk secretion and apoptosis during mammary involution.

Authors:  C J Wilde; C H Knight; D J Flint
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

2.  Localization of the death domain of tissue inhibitor of metalloproteinase-3 to the N terminus. Metalloproteinase inhibition is associated with proapoptotic activity.

Authors:  M Bond; G Murphy; M R Bennett; A Amour; V Knauper; A C Newby; A H Baker
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

3.  ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3.

Authors:  F Loechel; J W Fox; G Murphy; R Albrechtsen; U M Wewer
Journal:  Biochem Biophys Res Commun       Date:  2000-11-30       Impact factor: 3.575

4.  The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development.

Authors:  J E Fata; Y Y Kong; J Li; T Sasaki; J Irie-Sasaki; R A Moorehead; R Elliott; S Scully; E B Voura; D L Lacey; W J Boyle; R Khokha; J M Penninger
Journal:  Cell       Date:  2000-09-29       Impact factor: 41.582

5.  Mutations in the heparin binding domain of fibronectin in cooperation with the V region induce decreases in pp125(FAK) levels plus proteoglycan-mediated apoptosis via caspases.

Authors:  Y L Kapila; S Wang; P W Johnson
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

Review 6.  Adamalysins. A family of metzincins including TNF-alpha converting enzyme (TACE).

Authors:  L Killar; J White; R Black; J Peschon
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691

7.  Roles of Fas and Fas ligand during mammary gland remodeling.

Authors:  J Song; E Sapi; W Brown; J Nilsen; K Tartaro; B M Kacinski; J Craft; F Naftolin; G Mor
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 8.  Adipose cell apoptosis: death in the energy depot.

Authors:  A Sorisky; R Magun; A M Gagnon
Journal:  Int J Obes Relat Metab Disord       Date:  2000-11

9.  Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1.

Authors:  V Noë; B Fingleton; K Jacobs; H C Crawford; S Vermeulen; W Steelant; E Bruyneel; L M Matrisian; M Mareel
Journal:  J Cell Sci       Date:  2001-01       Impact factor: 5.285

10.  Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1.

Authors:  D C Martin; J L Fowlkes; B Babic; R Khokha
Journal:  J Cell Biol       Date:  1999-08-23       Impact factor: 10.539

View more
  61 in total

Review 1.  That impish TIMP: the tissue inhibitor of metalloproteinases-3.

Authors:  J F Woessner
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

2.  Metalloproteases and adipogenesis: a weighty subject.

Authors:  Jennifer Lilla; Dominique Stickens; Zena Werb
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 3.  Do inflammatory cells participate in mammary gland involution?

Authors:  Jenifer Monks; F Jon Geske; Lisa Lehman; Valerie A Fadok
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

Review 4.  Apoptosis regulation in the mammary gland.

Authors:  K A Green; C H Streuli
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

Review 5.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 6.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

7.  Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein.

Authors:  Ki-Kyung Jung; Xu-Wen Liu; Rosemarie Chirco; Rafael Fridman; Hyeong-Reh Choi Kim
Journal:  EMBO J       Date:  2006-08-17       Impact factor: 11.598

8.  Tissue inhibitor of metalloproteinases 3 regulates resolution of inflammation following acute lung injury.

Authors:  Sean E Gill; Isham Huizar; Eli M Bench; Samuel W Sussman; Ying Wang; Rama Khokha; William C Parks
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

9.  Low tissue inhibitor of metalloproteinases 3 and high matrix metalloproteinase 14 levels defines a subpopulation of highly invasive foam-cell macrophages.

Authors:  Jason L Johnson; Graciela B Sala-Newby; Yasmin Ismail; Concepción M Aguilera; Andrew C Newby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-19       Impact factor: 8.311

10.  Differences between scirrhous and non-scirrhous human gastric carcinomas from the aspect of proMMP-2 activation regulated by TIMP-3.

Authors:  Takeyoshi Yokoyama; Hiroyuki Nakamura; Yoshihide Otani; Tetsuro Kubota; Noboru Fujimoto; Motoharu Seiki; Masaki Kitajima; Yasunori Okada
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.